Does BEVACIZUMAB Cause Hepatic cirrhosis? 188 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 188 reports of Hepatic cirrhosis have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 0.2% of all adverse event reports for BEVACIZUMAB.
188
Reports of Hepatic cirrhosis with BEVACIZUMAB
0.2%
of all BEVACIZUMAB reports
54
Deaths
64
Hospitalizations
How Dangerous Is Hepatic cirrhosis From BEVACIZUMAB?
Of the 188 reports, 54 (28.7%) resulted in death, 64 (34.0%) required hospitalization, and 16 (8.5%) were considered life-threatening.
Is Hepatic cirrhosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 188 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hepatic cirrhosis?
ADALIMUMAB (1,760)
METHOTREXATE (1,650)
ETANERCEPT (931)
TOCILIZUMAB (903)
RITUXIMAB (863)
INFLIXIMAB (831)
ABATACEPT (824)
HYDROXYCHLOROQUINE (807)
LEFLUNOMIDE (780)
SULFASALAZINE (760)
Which BEVACIZUMAB Alternatives Have Lower Hepatic cirrhosis Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ